Mindbloom
Clinical platform offering guided, at-home ketamine therapy for anxiety and depression.
What they do
Mindbloom is a telemedicine platform delivering guided ketamine therapy for depression and anxiety. Customers receive home-delivered treatments, clinical management from psychiatric clinicians, and preparation and integration coaching from trained guides via video.
The record
- Vertical
- Mental & Behavioural Health
- Sub-segment
- Psychedelic-assisted therapy
- Product type
- Service
- Stage
- Series A
- Headquarters
- Austin, USA
- Region
- North America
- Founded
- 2018
- Total funding
- $36M raised
Notable investors: Founders Fund, 8VC, Defining Ventures.